<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9619918" created="18/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9619918</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T2" lex="IL-2" sem="Protein_molecule">IL-2</term>-induced <term id="T51" sem="Other">growth</term> of <term id="T3" lex="CD8+_T_cell_prolymphocytic_leukemia_cell" sem="Cell_natural">CD8+ T cell prolymphocytic leukemia cells</term> mediated by <term id="T4" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> induction and <term id="T5" lex="IL-2_receptor_alpha_expression" sem="Other"><term id="T6" lex="IL-2_receptor_alpha" sem="Protein_molecule"><term id="T7" lex="IL-2" sem="Protein_molecule">IL-2</term> receptor alpha</term> expression</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T2"/>
<clue>IL-2-<clueType>induced</clueType> growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression.</clue>
</event>
<event KT="Other" id="E30">
<type class="Cellular_physiological_process"/>
<theme idref="T3"/>
<clue>IL-2-induced <clueType>growth</clueType> <linkTheme>of</linkTheme> CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="E4"/>
<clue>IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells <clueType>mediated</clueType> <linkCause>by</linkCause> NF-kappaB induction and IL-2 receptor alpha expression.</clue>
</event>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="E5"/>
<clue>IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells <clueType>mediated</clueType> <linkCause>by</linkCause> NF-kappaB induction and IL-2 receptor alpha expression.</clue>
</event>
<event KT="Other" id="E4">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<clue>IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB <clueType>induction</clueType> and IL-2 receptor alpha expression.</clue>
</event>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha <clueType>expression</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The binding of <term id="T8" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term> (<term id="T9" lex="IL-2" sem="Protein_molecule">IL-2</term>) to its <term id="A2" sem="Protein_molecule">receptor</term> on normal <term id="T10" lex="T_cell" sem="Cell_natural">T cells</term> induces <term id="T11" lex="nuclear_expression" sem="Other"><term id="T1" sem="Cell_component">nuclear</term> expression</term> of <term id="T12" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> (<term id="T13" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>), activation of the <term id="T14" lex="IL-2_receptor_(IL-2R)_alpha_chain_gene" sem="DNA_domain_or_region"><term id="T15" lex="IL-2_receptor_(IL-2R)_alpha_chain" sem="Protein_molecule"><term id="T16" lex="IL-2_receptor" sem="Protein_family_or_group"><term id="T17" lex="IL-2" sem="Protein_molecule">IL-2</term> receptor</term> (IL-2R) alpha chain</term> gene</term>, and <term id="T18" lex="cell_proliferation" sem="Other"><term id="A3" sem="Cell_natural">cell</term> proliferation</term>.</sentence>
<event KT="Other" id="E6">
<type class="Binding"/>
<theme idref="T9"/>
<theme idref="A2"/>
<clue>The <clueType>binding</clueType> <linkTheme>of</linkTheme> interleukin-2 (IL-2) <linkTheme>to</linkTheme> its receptor <clueLoc>on normal T cells</clueLoc> induces nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E6"/>
<clue>The binding of interleukin-2 (IL-2) to its receptor on normal T cells <clueType>induces</clueType> nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="E6"/>
<clue>The binding of interleukin-2 (IL-2) to its receptor on normal T cells <clueType>induces</clueType> nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E6"/>
<clue>The binding of interleukin-2 (IL-2) to its receptor on normal T cells <clueType>induces</clueType> nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation.</clue>
</event>
<event KT="Other" id="E10">
<type class="Localization"/>
<theme idref="T13"/>
<clue>The binding of interleukin-2 (IL-2) to its receptor on normal T cells induces <clueLoc>nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<clue>The binding of interleukin-2 (IL-2) to its receptor on normal T cells induces nuclear expression of nuclear factor kappaB (NF-kappaB), <clueType>activation</clueType> <linkTheme>of</linkTheme> the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation.</clue>
</event>
<event KT="Other" id="E12">
<type class="Cellular_physiological_process"/>
<theme idref="A3"/>
<clue>The binding of interleukin-2 (IL-2) to its receptor on normal T cells induces nuclear expression of nuclear factor kappaB (NF-kappaB), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell <clueType>proliferation</clueType>.</clue>
</event>
<sentence id="S3">In the present study, the role of <term id="T19" lex="IL-2R" sem="Protein_family_or_group">IL-2R</term> signaling in the growth of <term id="T20" lex="CD8+_T_cell_prolymphocytic_leukemia_(T-PLL)_cells" sem="Cell_cultured">CD8+ T cell prolymphocytic leukemia (T-PLL) cells</term> has been investigated.</sentence>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="E14"/>
<clue>In the present study, the <clueType>role</clueType> <linkCause>of</linkCause> IL-2R signaling <linkTheme>in</linkTheme> the growth of CD8+ T cell prolymphocytic leukemia (T-PLL) cells has been <clueKT>investigated</clueKT>.</clue>
</event>
<event KT="Other" id="E14">
<type class="Cell_communication"/>
<theme idref="T19"/>
<clue>In the present study, the role of IL-2R <clueType>signaling</clueType> in the growth of CD8+ T cell prolymphocytic leukemia (T-PLL) cells has been investigated.</clue>
</event>
<event KT="Other" id="E15">
<type class="Cellular_physiological_process"/>
<theme idref="T20"/>
<clue>In the present study, the role of IL-2R signaling in the <clueType>growth</clueType> <linkTheme>of</linkTheme> CD8+ T cell prolymphocytic leukemia (T-PLL) cells has been investigated.</clue>
</event>
<sentence id="S4">Flow cytometry revealed that <term id="T21" lex="primary_leukemia_cell" sem="Cell_natural">primary leukemia cells</term> from a patient with <term id="T22" lex="CD8+_T-PLL" sem="Other">CD8+ T-PLL</term> expressed <cons id="T23" lex="(AND IL-2Ralpha_chain IL-2Rbeta_chain)" sem="(AND Protein_molecule Protein_molecule)"><frag id="F1"><term id="A4" sem="Protein_molecule">IL-2R</term></frag><frag id="F2"><term id="A5" sem="Protein_molecule">alpha</term></frag> and <frag id="F3"><term id="A6" sem="Protein_molecule">beta</term></frag> <frag id="F4">chains</frag></cons>, and the cells showed a proliferative response and an increase in <term id="T24" lex="IL-2Ralpha_expression" sem="Other"><term id="T25" lex="IL-2Ralpha" sem="Protein_molecule">IL-2Ralpha</term> expression</term> on culture with exogeneous <term id="T26" lex="IL-2" sem="Protein_molecule">IL-2</term>.</sentence>
<event KT="Analysis" id="E16">
<type class="Gene_expression"/>
<theme idref="A4" idref1="A5"/>
<clue><clueExperiment>Flow cytometry</clueExperiment> <clueKT>revealed</clueKT> that <clueLoc>primary leukemia cells from a patient with CD8+ T-PLL</clueLoc> <clueType>expressed</clueType> IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2.</clue>
</event>
<event KT="Analysis" id="E17">
<type class="Gene_expression"/>
<theme idref="A4" idref1="A6"/>
<clue><clueExperiment>Flow cytometry</clueExperiment> <clueKT>revealed</clueKT> that <clueLoc>primary leukemia cells from a patient with CD8+ T-PLL</clueLoc> <clueType>expressed</clueType> IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2.</clue>
</event>
<event KT="Other" id="E18">
<type class="Cellular_physiological_process"/>
<theme idref="T21"/>
<clue>Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and <corefTheme>the cells</corefTheme> showed a <clueType>proliferative</clueType> response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2.</clue>
</event>
<event KT="Analysis" id="E21">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="T26"/>
<clue>Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells <clueKT>showed</clueKT> a proliferative <clueType>response</clueType> and an increase in IL-2Ralpha expression on culture <linkCause>with</linkCause> exogeneous IL-2.</clue>
</event>
<event KT="Analysis" id="E19">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T26"/>
<clue>Flow cytometry revealed that <clueLoc>primary leukemia cells</clueLoc> from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells <clueKT>showed</clueKT> a proliferative response and an <clueType>increase</clueType> <linkTheme>in</linkTheme> IL-2Ralpha expression on culture <linkCause>with</linkCause> exogeneous IL-2.</clue>
</event>
<event KT="Other" id="E20">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue>Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha <clueType>expression</clueType> on culture with exogeneous IL-2.</clue>
</event>
<sentence id="S5"><term id="T27" lex="northern_blot_analysis" sem="Other">Northern blot analysis</term> failed to detect <term id="T28" lex="IL-2_mRNA" sem="RNA_molecule">IL-2 mRNA</term>, suggesting that <term id="T29" lex="IL-2" sem="Protein_molecule">IL-2</term> may act in a paracrine manner in vivo.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Transcription"/>
<theme idref="T28"/>
<clue><clueExperiment>Northern blot analysis</clueExperiment> <cluePolarity>failed</cluePolarity> to <clueType><clueKT>detect</clueKT></clueType> IL-2 mRNA, suggesting that IL-2 may act in a paracrine manner in vivo.</clue>
</event>
<event CL="L1" KT="Analysis" id="E23" uncertainty="probable">
<type class="Cell_communication"/>
<theme idref="T29"/>
<clue>Northern blot analysis failed to detect IL-2 mRNA, <clueKT>suggesting</clueKT> that IL-2 <clueCL>may</clueCL> <clueType>act in a paracrine manner</clueType> in vivo.</clue>
</event>
<sentence id="S6"><term id="T30" lex="electrophoretic_mobility-shift_assay" sem="Other">Electrophoretic mobility-shift assays</term> revealed that recombinant <term id="T31" lex="IL-2" sem="Protein_molecule">IL-2</term> increased <term id="T32" lex="NF-kappaB_binding_activity" sem="Other"><term id="T33" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding activity</term> in <term id="T34" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> of the <term id="T35" lex="leukemia_cell" sem="Cell_natural">leukemia cells</term>, and <term id="T36" lex="northern_blot_analysis" sem="Other">Northern blot analysis</term> showed that <term id="T37" lex="IL-2" sem="Protein_molecule">IL-2</term> increased the abundance of mRNAs encoding the <term id="T38" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> components <term id="T39" lex="c-Rel" sem="Protein_molecule">c-Rel</term> and <term id="T40" lex="KBF1" sem="Protein_molecule">KBF1</term> in these cells.</sentence>
<event KT="Analysis" id="E24">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="T31"/>
<clue><clueExperiment>Electrophoretic mobility-shift assays</clueExperiment> <clueKT>revealed</clueKT> that recombinant IL-2 <clueType>increased</clueType> NF-kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL-2 increased the abundance of mRNAs encoding the NF-kappaB components c-Rel and KBF1 in these cells.</clue>
</event>
<event KT="Other" id="E25">
<type class="Binding"/>
<theme idref="T33"/>
<clue>Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB <clueType>binding activity</clueType> <clueLoc>in nuclear extracts of the leukemia cells</clueLoc>, and Northern blot analysis showed that IL-2 increased the abundance of mRNAs encoding the NF-kappaB components c-Rel and KBF1 in these cells.</clue>
</event>
<event KT="Analysis" id="E26">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="T37"/>
<clue>Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB binding activity in nuclear extracts of the leukemia cells, and <clueExperiment>Northern blot analysis</clueExperiment> <clueKT>showed</clueKT> that IL-2 <clueType>increased</clueType> the abundance of mRNAs encoding the NF-kappaB components c-Rel and KBF1 in these cells.</clue>
</event>
<event KT="Analysis" id="E27">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T37"/>
<clue>Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB binding activity in nuclear extracts of the leukemia cells, and <clueExperiment>Northern blot analysis</clueExperiment> <clueKT>showed</clueKT> that IL-2 <clueType>increased</clueType> the abundance of mRNAs encoding the NF-kappaB components c-Rel and KBF1 in these cells.</clue>
</event>
<event KT="Other" id="E28">
<type class="Transcription"/>
<theme idref="T39"/>
<clue>Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL-2 increased the <clueType>abundance of mRNAs</clueType> <linkTheme>encoding</linkTheme> the NF-kappaB components c-Rel and KBF1 <clueLoc>in these cells</clueLoc>.</clue>
<comment>CAUTION</comment></event>
<event KT="Other" id="E29">
<type class="Transcription"/>
<theme idref="T40"/>
<clue>Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL-2 increased the <clueType>abundance of mRNAs</clueType> <linkTheme>encoding</linkTheme> the NF-kappaB components c-Rel and KBF1 <clueLoc>in these cells</clueLoc>.</clue>
<comment>CAUTION</comment></event>
<sentence id="S7"><term id="T41" lex="IL-2" sem="Protein_molecule">IL-2</term> binding analysis demonstrated that <term id="T42" lex="IL-2" sem="Protein_molecule">IL-2</term> markedly increased the number of <term id="A1" sem="Protein_family_or_group">low affinity <term id="T43" lex="IL-2R" sem="Protein_family_or_group">IL-2Rs</term></term> on the <term id="T44" lex="leukemia_cell" sem="Cell_natural">leukemia cells</term>, without an effect on the number of <term id="T45" lex="high-affinity_IL-2R" sem="Protein_family_or_group">high-affinity IL-2Rs</term>.</sentence>
<event KT="Investigation" id="E31" uncertainty="doubtful">
<type class="Binding"/>
<theme idref="T41"/>
<theme idref="T43"/>
<clue>IL-2 <clueType>binding</clueType> <clueKT>analysis</clueKT> demonstrated that IL-2 markedly increased the number of low affinity IL-2Rs on the leukemia cells, without an effect on the number of high-affinity IL-2Rs.</clue>
</event>
<event KT="Analysis" Manner="High" id="E32">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<cause idref="T42"/>
<clue>IL-2 binding analysis <clueKT>demonstrated</clueKT> that IL-2 <clueManner>markedly</clueManner> <clueType>increased</clueType> the number of low affinity IL-2Rs <clueLoc>on the leukemia cells</clueLoc>, without an effect on the number of high-affinity IL-2Rs.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E33">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<cause idref="T42"/>
<clue>IL-2 binding analysis <clueKT>demonstrated</clueKT> that IL-2 markedly increased the number of low affinity IL-2Rs on the leukemia cells, <cluePolarity>without</cluePolarity> an <clueType>effect</clueType> <linkTheme>on</linkTheme> the number of high-affinity IL-2Rs.</clue>
</event>
<sentence id="S8">These results show that <term id="T46" lex="IL-2" sem="Protein_molecule">IL-2</term> is capable of inducing the <term id="T47" lex="nuclear_expression" sem="Other"><term id="T52" sem="Cell_component">nuclear</term> expression</term> of <term id="T48" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in <term id="T49" lex="primary_CD8+_T-PLL_cell" sem="Cell_cultured">primary CD8+ T-PLL cells</term>, and that this effect is mediated, at least in part, at a pretranslational level.</sentence>
<event CL="L2" KT="Analysis" id="E34">
<type class="Positive_regulation"/>
<theme idref="E35"/>
<cause idref="T46"/>
<clue>These results <clueKT>show</clueKT> that IL-2 is <clueCL>capable</clueCL> of <clueType>inducing</clueType> the nuclear expression of NF-kappaB in primary CD8+ T-PLL cells, and that this effect is mediated, at least in part, at a pretranslational level.</clue>
</event>
<event KT="Other" id="E35">
<type class="Localization"/>
<theme idref="T48"/>
<clue>These results show that IL-2 is capable of inducing the <clueLoc>nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> NF-kappaB <clueLoc>in primary CD8+ T-PLL cells</clueLoc>, and that this effect is mediated, at least in part, at a pretranslational level.</clue>
</event>
<event KT="Analysis" id="E36">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<clue>These results <clueKT>show</clueKT> that IL-2 is capable of inducing the nuclear expression of NF-kappaB in primary CD8+ T-PLL cells, and that this effect is <clueType>mediated</clueType>, at least in part, at a pretranslational level.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
